Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: LINC00922 acts as a novel oncogene in gastric cancer

Fig. 4

MiR-204-5p suppresses GC progression in vitro. MiR-204-5p mimic or inhibitor was transfected to MKN-45 and HGC-27. A The transfection efficiency was certified by qRT-PCR assay. B CCK-8 assay was performed to investigate the proliferation. C Transwell assay was used to investigate the migration and invasion. D Flow cytometry assay was used to assess cell apoptosis. *P < 0.05, **P < 0.01, ***P < 0.001 vs. NC mimic group, ##P < 0.01, ### P < 0.001 vs. NC inhibitor group

Back to article page